Magnesium in PDB 4jvj: Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate
Enzymatic activity of Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate
All present enzymatic activity of Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate:
2.5.1.1;
2.5.1.10;
Protein crystallography data
The structure of Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate, PDB code: 4jvj
was solved by
J.Park,
C.-Y.Leung,
Y.S.Tsantrizos,
A.M.Berghuis,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.84 /
2.80
|
Space group
|
P 41 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
111.330,
111.330,
67.462,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
23.6 /
28.8
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate
(pdb code 4jvj). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 3 binding sites of Magnesium where determined in the
Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate, PDB code: 4jvj:
Jump to Magnesium binding site number:
1;
2;
3;
Magnesium binding site 1 out
of 3 in 4jvj
Go back to
Magnesium Binding Sites List in 4jvj
Magnesium binding site 1 out
of 3 in the Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Mg403
b:52.0
occ:1.00
|
O
|
F:HOH514
|
2.0
|
49.4
|
1.0
|
OD2
|
F:ASP243
|
2.1
|
57.1
|
1.0
|
O
|
F:HOH513
|
2.1
|
57.4
|
1.0
|
OAW
|
F:1MV401
|
2.1
|
72.3
|
1.0
|
OAY
|
F:1MV401
|
2.9
|
78.7
|
1.0
|
PAS
|
F:1MV401
|
3.1
|
80.7
|
1.0
|
CAR
|
F:1MV401
|
3.2
|
78.9
|
1.0
|
PAT
|
F:1MV401
|
3.2
|
80.5
|
1.0
|
CG
|
F:ASP243
|
3.3
|
60.2
|
1.0
|
OAZ
|
F:1MV401
|
3.4
|
72.7
|
1.0
|
NE2
|
F:GLN240
|
3.6
|
61.5
|
1.0
|
OD1
|
F:ASP244
|
3.7
|
63.4
|
1.0
|
OD1
|
F:ASP243
|
4.0
|
61.8
|
1.0
|
OAV
|
F:1MV401
|
4.1
|
79.7
|
1.0
|
OD2
|
F:ASP247
|
4.2
|
64.5
|
1.0
|
CB
|
F:ASP243
|
4.2
|
61.4
|
1.0
|
OAU
|
F:1MV401
|
4.3
|
75.2
|
1.0
|
OD1
|
F:ASP261
|
4.6
|
71.2
|
1.0
|
OD2
|
F:ASP261
|
4.6
|
60.9
|
1.0
|
O
|
F:ASP243
|
4.6
|
58.0
|
1.0
|
C
|
F:ASP243
|
4.6
|
59.0
|
1.0
|
O
|
F:HOH512
|
4.6
|
50.7
|
1.0
|
NAJ
|
F:1MV401
|
4.7
|
83.5
|
1.0
|
N
|
F:ASP244
|
4.8
|
67.5
|
1.0
|
CD
|
F:GLN240
|
4.8
|
60.1
|
1.0
|
OAX
|
F:1MV401
|
4.8
|
72.2
|
1.0
|
CG
|
F:ASP244
|
4.9
|
64.5
|
1.0
|
MG
|
F:MG405
|
5.0
|
67.3
|
1.0
|
|
Magnesium binding site 2 out
of 3 in 4jvj
Go back to
Magnesium Binding Sites List in 4jvj
Magnesium binding site 2 out
of 3 in the Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Mg404
b:51.9
occ:1.00
|
OAV
|
F:1MV401
|
1.9
|
79.7
|
1.0
|
O
|
F:HOH511
|
2.0
|
27.9
|
1.0
|
O
|
F:HOH508
|
2.0
|
30.4
|
1.0
|
OD2
|
F:ASP107
|
2.2
|
50.6
|
1.0
|
PAS
|
F:1MV401
|
3.0
|
80.7
|
1.0
|
OD1
|
F:ASP103
|
3.1
|
70.2
|
1.0
|
OAU
|
F:1MV401
|
3.2
|
75.2
|
1.0
|
NZ
|
F:LYS266
|
3.2
|
67.3
|
1.0
|
CG
|
F:ASP107
|
3.3
|
55.6
|
1.0
|
MG
|
F:MG405
|
3.3
|
67.3
|
1.0
|
OD2
|
F:ASP103
|
3.4
|
62.1
|
1.0
|
OD1
|
F:ASP107
|
3.6
|
50.8
|
1.0
|
CG
|
F:ASP103
|
3.7
|
65.9
|
1.0
|
OAW
|
F:1MV401
|
3.7
|
72.3
|
1.0
|
OD2
|
F:ASP174
|
3.8
|
50.9
|
1.0
|
O
|
F:HOH512
|
3.9
|
50.7
|
1.0
|
NE2
|
F:GLN171
|
4.1
|
55.5
|
1.0
|
OE1
|
F:GLN171
|
4.2
|
50.6
|
1.0
|
CG
|
F:ASP174
|
4.2
|
54.0
|
1.0
|
OD1
|
F:ASP174
|
4.2
|
54.8
|
1.0
|
NZ
|
F:LYS200
|
4.3
|
50.0
|
1.0
|
OAZ
|
F:1MV401
|
4.5
|
72.7
|
1.0
|
CAR
|
F:1MV401
|
4.6
|
78.9
|
1.0
|
CE
|
F:LYS266
|
4.6
|
63.0
|
1.0
|
CD
|
F:GLN171
|
4.6
|
53.8
|
1.0
|
CB
|
F:ASP107
|
4.6
|
57.3
|
1.0
|
CAC
|
F:1MV401
|
4.8
|
96.2
|
1.0
|
NAJ
|
F:1MV401
|
4.9
|
83.5
|
1.0
|
O
|
F:HOH506
|
4.9
|
50.0
|
1.0
|
|
Magnesium binding site 3 out
of 3 in 4jvj
Go back to
Magnesium Binding Sites List in 4jvj
Magnesium binding site 3 out
of 3 in the Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Crystal Structure of Human Fpps in Complex with Magnesium, CL01131, and Sulfate within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Mg405
b:67.3
occ:1.00
|
O
|
F:HOH512
|
1.9
|
50.7
|
1.0
|
OAZ
|
F:1MV401
|
2.1
|
72.7
|
1.0
|
OAV
|
F:1MV401
|
2.3
|
79.7
|
1.0
|
OD1
|
F:ASP103
|
2.3
|
70.2
|
1.0
|
OD2
|
F:ASP107
|
2.6
|
50.6
|
1.0
|
PAT
|
F:1MV401
|
3.3
|
80.5
|
1.0
|
MG
|
F:MG404
|
3.3
|
51.9
|
1.0
|
PAS
|
F:1MV401
|
3.5
|
80.7
|
1.0
|
CG
|
F:ASP107
|
3.6
|
55.6
|
1.0
|
CG
|
F:ASP103
|
3.6
|
65.9
|
1.0
|
OAX
|
F:1MV401
|
3.8
|
72.2
|
1.0
|
CB
|
F:ASP107
|
3.8
|
57.3
|
1.0
|
CAR
|
F:1MV401
|
3.9
|
78.9
|
1.0
|
NH2
|
F:ARG112
|
4.2
|
63.0
|
1.0
|
OAW
|
F:1MV401
|
4.2
|
72.3
|
1.0
|
O
|
F:HOH513
|
4.3
|
57.4
|
1.0
|
OD2
|
F:ASP103
|
4.4
|
62.1
|
1.0
|
NAJ
|
F:1MV401
|
4.4
|
83.5
|
1.0
|
OG
|
F:SER109
|
4.4
|
54.6
|
1.0
|
OD1
|
F:ASP104
|
4.4
|
71.2
|
1.0
|
CB
|
F:ASP103
|
4.5
|
61.5
|
1.0
|
O
|
F:ASP103
|
4.5
|
53.0
|
1.0
|
OAY
|
F:1MV401
|
4.6
|
78.7
|
1.0
|
O
|
F:HOH511
|
4.6
|
27.9
|
1.0
|
OAU
|
F:1MV401
|
4.7
|
75.2
|
1.0
|
OD1
|
F:ASP107
|
4.7
|
50.8
|
1.0
|
O
|
F:HOH506
|
4.8
|
50.0
|
1.0
|
O
|
F:HOH508
|
4.8
|
30.4
|
1.0
|
C
|
F:ASP103
|
4.9
|
55.0
|
1.0
|
MG
|
F:MG403
|
5.0
|
52.0
|
1.0
|
|
Reference:
C.Y.Leung,
J.Park,
J.W.De Schutter,
M.Sebag,
A.M.Berghuis,
Y.S.Tsantrizos.
Thienopyrimidine Bisphosphonate (Thpbp) Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Optimization and Characterization of the Mode of Inhibition. J.Med.Chem. V. 56 7939 2013.
ISSN: ISSN 0022-2623
PubMed: 23998921
DOI: 10.1021/JM400946F
Page generated: Sat Aug 17 03:19:48 2024
|